My NCBISign In
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Johan Lindberg, Erik af Klint, Anca Irinel Catrina, Peter Nilsson, Lars Klareskog, Ann-Kristin Ulfgren, Joakim Lundeberg
Arthritis Res Ther. 2006; 8(6): R179. Published online 2006 November 29. doi: 10.1186/ar2090
PMCID:
PMC1794525
Abstract Full Text PDF–933K Supplementary Material

Is Cited by the Following 8 Articles in this Archive:

Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
Erik J. M. Toonen, Christian Gilissen, Barbara Franke, Wietske Kievit, Agnes M. Eijsbouts, Alfons A. den Broeder, Simon V. van Reijmersdal, Joris A. Veltman, Hans Scheffer, Timothy R. D. J. Radstake, Piet L. C. M. van Riel, Pilar Barrera, Marieke J. H. Coenen
PLoS One. 2012; 7(3): e33199. Published online 2012 March 21. doi: 10.1371/journal.pone.0033199
PMCID:
PMC3310059
Abstract Full Text PDF–165K Supplementary Material
A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm
Paul P. Tak
Rheumatology (Oxford) 2012 April; 51(4): 600–609. Published online 2011 September 2. doi: 10.1093/rheumatology/ker300
PMCID:
PMC3306168
Abstract Full Text PDF–217K
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
Johan Lindberg, Carla A. Wijbrandts, Lisa G. van Baarsen, Gustavo Nader, Lars Klareskog, Anca Catrina, Rogier Thurlings, Margriet Vervoordeldonk, Joakim Lundeberg, Paul P. Tak
PLoS One. 2010; 5(6): e11310. Published online 2010 June 25. doi: 10.1371/journal.pone.0011310
PMCID:
PMC2892481
Abstract Full Text PDF–366K Supplementary Material
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia
Thierry Lequerré, Carine Bansard, Olivier Vittecoq, Céline Derambure, Martine Hiron, Maryvonne Daveau, François Tron, Xavier Ayral, Norman Biga, Isabelle Auquit-Auckbur, Gilles Chiocchia, Xavier Le Loët, Jean-Philippe Salier
Arthritis Res Ther. 2009; 11(3): R99. Published online 2009 June 29. doi: 10.1186/ar2744
PMCID:
PMC2714155
Abstract Full Text PDF–402K Supplementary Material
Predicting the future of anti-tumor necrosis factor therapy
Cornelis L Verweij
Arthritis Res Ther. 2009; 11(3): 115. Published online 2009 June 22. doi: 10.1186/ar2724
PMCID:
PMC2714140
Abstract Full Text PDF–45K
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
Valérie Badot, Christine Galant, Adrien Nzeusseu Toukap, Ivan Theate, Anne-Lise Maudoux, Benoît J Van den Eynde, Patrick Durez, Frédéric A Houssiau, Bernard R Lauwerys
Arthritis Res Ther. 2009; 11(2): R57. Published online 2009 April 23. doi: 10.1186/ar2678
PMCID:
PMC2688209
Abstract Full Text PDF–2.2M Supplementary Material
Transcription profiling of rheumatic diseases
Lisa GM van Baarsen, Carina L Bos, Tineke CTM van der Pouw Kraan, Cornelis L Verweij
Arthritis Res Ther. 2009; 11(1): 207. Published online 2009 January 30. doi: 10.1186/ar2557
PMCID:
PMC2688218
Abstract Full Text PDF–866K
Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
Dirk Koczan, Susanne Drynda, Michael Hecker, Andreas Drynda, Reinhard Guthke, Joern Kekow, Hans-Juergen Thiesen
Arthritis Res Ther. 2008; 10(3): R50. Published online 2008 May 2. doi: 10.1186/ar2419
PMCID:
PMC2483439
Abstract Full Text PDF–564K Supplementary Material
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk